Author:
Freifeld Yuval,Dekel Yoram,Stein Avi
Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. Babjuk M, Oosterlinck W, Sylvester R, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. Actas Urol Esp. 2012;36(7):389–402.
2. Malmström PU, Sylvester RJ, Crawford DE, et al. An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer. Eur Urol. 2009;56(2):247–56.
3. Soloway MS, Jordan AM, Murphy WM. Rationale for intravesical chemotherapy in the treatment and prophylaxis of superficial transitional cell carcinoma. Prog Clin Biol Res. 1989;310:215–36.
4. De Nunzio C, Carbone A, Albisinni S, et al. Long-term experience with early single mitomycin C instillations in patients with low-risk non-muscle-invasive bladder cancer: prospective, single-centre randomised trial. World J Urol. 2011;29(4):517–21.
5. Wientjes MG, Dalton JT, Badalament RA, et al. Bladder wall penetration of intravesical mitomycin C in dogs. Cancer Res. 1991;51(16):4347–54.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献